• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中的外周气道功能与疾病负担

Peripheral airway function and disease burden in COPD.

作者信息

Färdig Martin, Lingman Karin, Lisspers Karin, Ställberg Björn, Janson Christer, Högman Marieann, Malinovschi Andrei

机构信息

Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.

These authors contributed equally.

出版信息

ERJ Open Res. 2025 Aug 4;11(4). doi: 10.1183/23120541.01078-2024. eCollection 2025 Jul.

DOI:10.1183/23120541.01078-2024
PMID:40761654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12320105/
Abstract

BACKGROUND

While oscillometry appears advantageous over spirometry in detecting peripheral airway dysfunction, a feature of COPD, further research on its role in disease monitoring is needed. The objectives of the present study were to analyse the associations between oscillometry by impulse oscillometry (IOS) and forced oscillation technique (FOT) and airway obstruction, health status, dyspnoea and future exacerbations in COPD.

METHODS

Oscillometry and disease burden were assessed in 150 adults with COPD within the Tools Identifying Exacerbations study. At 5 Hz, abnormal resistance ( ) and reactance ( ) were defined as -scores >1.645 and <-1.645 sd, respectively, whereas a mean difference in reactance between inspiration and expiration >2.80 cmHO·L·s represented abnormal Δ . Forced expiratory volume in 1 s (FEV), COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) scores were obtained. Medical records were reviewed for future exacerbations (≥1) between baseline and 1 and 3 years, respectively.

RESULTS

Abnormal oscillometry correlated with disease burden, with the highest risk observed for severe airway obstruction (FEV <50% pred): odds ratios with 95% confidence intervals ranging from 4.80 (1.93-12.0) to 18.0 (7.13-45.3) for , and Δ , followed by moderate to severe dyspnoea (mMRC ≥2) for Δ , COPD health status (CAT ≥10) for and Δ and future exacerbations (1 and 3 years) for and , respectively, with odds ratios (95% CI) ranging from 2.77 (1.27-6.05) to 3.98 (1.38-11.5).

CONCLUSIONS

Abnormal oscillometry may be relevant in the evaluation of COPD patients, including the prediction of future exacerbation risk.

摘要

背景

虽然在检测慢性阻塞性肺疾病(COPD)的外周气道功能障碍这一特征方面,振荡法似乎比肺量计法更具优势,但仍需进一步研究其在疾病监测中的作用。本研究的目的是分析脉冲振荡法(IOS)和强迫振荡技术(FOT)进行的振荡法与COPD患者的气道阻塞、健康状况、呼吸困难及未来急性加重之间的关联。

方法

在“识别急性加重的工具”研究中,对150例成年COPD患者进行了振荡法和疾病负担评估。在5Hz时,异常阻力( )和电抗( )分别定义为z分数>1.645和<-1.645标准差,而吸气与呼气之间电抗的平均差值>2.80cmH₂O·L⁻¹·s表示异常ΔX。获取第1秒用力呼气量(FEV₁)、COPD评估测试(CAT)和改良医学研究委员会(mMRC)评分。回顾病历以了解基线与1年及3年之间未来的急性加重情况(≥1次)。

结果

异常振荡法与疾病负担相关,在严重气道阻塞(FEV₁<50%预计值)时观察到的风险最高:对于 、 和ΔX,比值比及其95%置信区间范围为4.80(从1.93至12.0)至18.0(从7.13至45.3),其次,对于ΔX是中度至重度呼吸困难(mMRC≥2),对于 和ΔX是COPD健康状况(CAT≥10),对于 和 分别是未来急性加重(1年和3年),比值比(95%CI)范围为2.77(从1.27至6.05)至3.98(从1.38至11.5)。

结论

异常振荡法可能在COPD患者评估中具有相关性,包括对未来急性加重风险的预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f446/12320105/4154e49c2e34/01078-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f446/12320105/a9b5d0d89e8e/01078-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f446/12320105/4154e49c2e34/01078-2024.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f446/12320105/a9b5d0d89e8e/01078-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f446/12320105/4154e49c2e34/01078-2024.02.jpg

相似文献

1
Peripheral airway function and disease burden in COPD.慢性阻塞性肺疾病中的外周气道功能与疾病负担
ERJ Open Res. 2025 Aug 4;11(4). doi: 10.1183/23120541.01078-2024. eCollection 2025 Jul.
2
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
3
The Impact of Age and Disease Entity on Small Airway Dysfunction in Obstructive Airway Diseases.年龄和疾病实体对阻塞性气道疾病中小气道功能障碍的影响。
Int J Chron Obstruct Pulmon Dis. 2025 Mar 27;20:821-830. doi: 10.2147/COPD.S505855. eCollection 2025.
4
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
5
Evaluation of the Effects of Switching COPD Patients From LAMA/LABA Therapy to ICS/LAMA/LABA Therapy Using the Impulse Oscillation System (IOS) Capable of Separating Inspiratory and Expiratory Measurements.使用能够分离吸气和呼气测量的脉冲振荡系统(IOS)评估慢性阻塞性肺疾病(COPD)患者从长效抗胆碱能药物/长效β2受体激动剂(LAMA/LABA)治疗转换为吸入性糖皮质激素/长效抗胆碱能药物/长效β2受体激动剂(ICS/LAMA/LABA)治疗的效果。
Clin Respir J. 2025;19(7):e70105. doi: 10.1111/crj.70105.
6
Vitamin D for the management of chronic obstructive pulmonary disease.维生素D用于慢性阻塞性肺疾病的管理
Cochrane Database Syst Rev. 2024 Sep 27;9(9):CD013284. doi: 10.1002/14651858.CD013284.pub2.
7
Comparison of oscillometry with lung function parameters between patients with stable bronchial asthma with airflow obstruction and chronic obstructive pulmonary disease.气流受限的稳定期支气管哮喘患者与慢性阻塞性肺疾病患者的振荡法与肺功能参数比较
BMC Pulm Med. 2025 Jul 10;25(1):333. doi: 10.1186/s12890-025-03754-2.
8
Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.吸入性皮质类固醇联合吸入长效β2-激动剂和长效抗胆碱能药物治疗慢性阻塞性肺疾病。
Cochrane Database Syst Rev. 2023 Dec 6;12(12):CD011600. doi: 10.1002/14651858.CD011600.pub3.
9
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.联合使用皮质类固醇和长效β2受体激动剂的单一吸入器与长效β2受体激动剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD006829. doi: 10.1002/14651858.CD006829.pub2.
10
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病(COPD)药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.

本文引用的文献

1
Expiratory and inspiratory resistance and reactance from respiratory oscillometry defining expiratory flow limitation in obstructive lung diseases.呼吸震荡测量法测定呼气和吸气阻力及电抗,以明确阻塞性肺部疾病中的呼气流量受限。
Clin Physiol Funct Imaging. 2024 Nov;44(6):426-435. doi: 10.1111/cpf.12895. Epub 2024 Jun 14.
2
Oscillometry-Defined Small Airway Dysfunction in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者中振荡法定义的小气道功能障碍
Tuberc Respir Dis (Seoul). 2024 Apr;87(2):165-175. doi: 10.4046/trd.2023.0139. Epub 2024 Jan 16.
3
Diagnostic Potential of Oscillometry: A Population-based Approach.
振荡测量法的诊断潜力:一种基于人群的方法。
Am J Respir Crit Care Med. 2024 Feb 15;209(4):444-453. doi: 10.1164/rccm.202306-0975OC.
4
Impulse oscillometry indices in relation to respiratory symptoms and spirometry in the Swedish Cardiopulmonary Bioimage Study.瑞典心肺生物影像研究中与呼吸症状及肺功能测定相关的脉冲振荡法指标
ERJ Open Res. 2023 Sep 25;9(5). doi: 10.1183/23120541.00736-2022. eCollection 2023 Sep.
5
FEV/FVC Severity Stages for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的 FEV/FVC 严重程度分期。
Am J Respir Crit Care Med. 2023 Sep 15;208(6):676-684. doi: 10.1164/rccm.202303-0450OC.
6
Assessment of small airway dysfunction by impulse oscillometry (IOS) in COPD and IPF patients.脉冲震荡法(IOS)评估 COPD 和特发性肺纤维化患者的小气道功能障碍。
Eur Rev Med Pharmacol Sci. 2023 Apr;27(7):3033-3044. doi: 10.26355/eurrev_202304_31937.
7
Clinical characteristics of airway impairment assessed by impulse oscillometry in patients with chronic obstructive pulmonary disease: findings from the ECOPD study in China.脉冲震荡法评估慢性阻塞性肺疾病患者气道损害的临床特征:来自中国 ECOPD 研究的结果。
BMC Pulm Med. 2023 Feb 3;23(1):52. doi: 10.1186/s12890-023-02311-z.
8
Physiological Impairments on Respiratory Oscillometry and Future Exacerbations in Chronic Obstructive Pulmonary Disease Patients without a History of Frequent Exacerbations.无频繁急性加重史的慢性阻塞性肺疾病患者呼吸振荡测量的生理损害与未来急性加重的关系。
COPD. 2022;19(1):149-157. doi: 10.1080/15412555.2022.2051005.
9
Expiratory flow limitation in a cohort of highly symptomatic COPD patients.一组高度症状性慢性阻塞性肺疾病患者的呼气气流受限
ERJ Open Res. 2022 Apr 4;8(2). doi: 10.1183/23120541.00680-2021. eCollection 2022 Apr.
10
Clinical significance and applications of oscillometry.容积描记法的临床意义和应用。
Eur Respir Rev. 2022 Feb 9;31(163). doi: 10.1183/16000617.0208-2021. Print 2022 Mar 31.